Matches in SemOpenAlex for { <https://semopenalex.org/work/W2988401315> ?p ?o ?g. }
- W2988401315 abstract "Background— In SPRINT (Systolic Blood Pressure Intervention Trial), patients with hypertension and high cardiovascular risk treated with intensive blood pressure (BP) control (<120 mm Hg) had fewer major adverse cardiovascular events (MACE) and deaths but higher rates of treatment-related serious adverse events (SAE) than patients randomized to standard BP control (<140 mm Hg). However, the degree of benefit or harm for an individual patient could vary because of heterogeneity in treatment effect. Methods and Results— Using patient-level data from 9361 randomized patients in SPRINT, we developed models to predict risk for MACE or death and treatment-related SAE to allow for individualized BP treatment goals based on each patient’s projected risk and benefit of intensive versus standard BP control. Models were internally validated using bootstrap resampling and externally validated on 4741 patients from the ACCORD-BP (The Action to Control Cardiovascular Risk in Diabetes blood pressure) trial. Among 9361 SPRINT patients, 755 patients (8.1%) had a MACE or death event and 338 patients (3.6%) had a treatment-related SAE during a median follow-up of 3.3 years. The MACE/death and the SAE model had C statistics of 0.72 and 0.70, respectively, in the derivation cohort and 0.69 and 0.65 in ACCORD. The MACE/death model had 10 variables including treatment interactions with age, baseline systolic BP, and diastolic BP, and the SAE model had 8 variables including treatment interaction with number of BP medications. Intensive BP treatment was associated with a mean 2.2±2.6% lower risk of MACE/death compared with standard treatment (range, 20.7% lower risk to 19.6% greater risk among individual patients) and a mean 2.2±1.2% higher risk for SAEs (range, 0.5%–15.8% more harm in individual patients). Conclusions— To translate the findings from SPRINT to clinical practice, we developed prediction models to tailor the intensity of BP control based on the projected risk and benefit for each unique patient. This approach should be prospectively tested to better engage patients in shared medical decision making and to improve outcomes. Clinical Trial Registration— URL: https://clinicaltrials.gov . Unique identifier: NCT01206062." @default.
- W2988401315 created "2019-11-22" @default.
- W2988401315 creator A5015021993 @default.
- W2988401315 creator A5027784504 @default.
- W2988401315 creator A5036864965 @default.
- W2988401315 creator A5061633865 @default.
- W2988401315 creator A5082758922 @default.
- W2988401315 creator A5086243822 @default.
- W2988401315 creator A5088259745 @default.
- W2988401315 date "2017-04-01" @default.
- W2988401315 modified "2023-09-25" @default.
- W2988401315 title "Personalizing the Intensity of Blood Pressure Control" @default.
- W2988401315 cites W1516497825 @default.
- W2988401315 cites W184158732 @default.
- W2988401315 cites W1978133266 @default.
- W2988401315 cites W2011840006 @default.
- W2988401315 cites W2048092130 @default.
- W2988401315 cites W2074932800 @default.
- W2988401315 cites W2077033046 @default.
- W2988401315 cites W2092075924 @default.
- W2988401315 cites W2116239162 @default.
- W2988401315 cites W2126125759 @default.
- W2988401315 cites W2128780239 @default.
- W2988401315 cites W2136145230 @default.
- W2988401315 cites W2137408480 @default.
- W2988401315 cites W2167353762 @default.
- W2988401315 cites W2223710100 @default.
- W2988401315 cites W2262071144 @default.
- W2988401315 cites W2437822687 @default.
- W2988401315 cites W2568119653 @default.
- W2988401315 cites W2586813559 @default.
- W2988401315 cites W3150595609 @default.
- W2988401315 cites W3175417087 @default.
- W2988401315 doi "https://doi.org/10.1161/circoutcomes.117.003624" @default.
- W2988401315 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5428922" @default.
- W2988401315 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28373269" @default.
- W2988401315 hasPublicationYear "2017" @default.
- W2988401315 type Work @default.
- W2988401315 sameAs 2988401315 @default.
- W2988401315 citedByCount "35" @default.
- W2988401315 countsByYear W29884013152017 @default.
- W2988401315 countsByYear W29884013152018 @default.
- W2988401315 countsByYear W29884013152019 @default.
- W2988401315 countsByYear W29884013152020 @default.
- W2988401315 countsByYear W29884013152021 @default.
- W2988401315 countsByYear W29884013152022 @default.
- W2988401315 countsByYear W29884013152023 @default.
- W2988401315 crossrefType "journal-article" @default.
- W2988401315 hasAuthorship W2988401315A5015021993 @default.
- W2988401315 hasAuthorship W2988401315A5027784504 @default.
- W2988401315 hasAuthorship W2988401315A5036864965 @default.
- W2988401315 hasAuthorship W2988401315A5061633865 @default.
- W2988401315 hasAuthorship W2988401315A5082758922 @default.
- W2988401315 hasAuthorship W2988401315A5086243822 @default.
- W2988401315 hasAuthorship W2988401315A5088259745 @default.
- W2988401315 hasBestOaLocation W29884013151 @default.
- W2988401315 hasConcept C126322002 @default.
- W2988401315 hasConcept C164705383 @default.
- W2988401315 hasConcept C168563851 @default.
- W2988401315 hasConcept C1862650 @default.
- W2988401315 hasConcept C194828623 @default.
- W2988401315 hasConcept C197934379 @default.
- W2988401315 hasConcept C2776868573 @default.
- W2988401315 hasConcept C2780400711 @default.
- W2988401315 hasConcept C2780739214 @default.
- W2988401315 hasConcept C500558357 @default.
- W2988401315 hasConcept C71924100 @default.
- W2988401315 hasConcept C72563966 @default.
- W2988401315 hasConcept C84393581 @default.
- W2988401315 hasConceptScore W2988401315C126322002 @default.
- W2988401315 hasConceptScore W2988401315C164705383 @default.
- W2988401315 hasConceptScore W2988401315C168563851 @default.
- W2988401315 hasConceptScore W2988401315C1862650 @default.
- W2988401315 hasConceptScore W2988401315C194828623 @default.
- W2988401315 hasConceptScore W2988401315C197934379 @default.
- W2988401315 hasConceptScore W2988401315C2776868573 @default.
- W2988401315 hasConceptScore W2988401315C2780400711 @default.
- W2988401315 hasConceptScore W2988401315C2780739214 @default.
- W2988401315 hasConceptScore W2988401315C500558357 @default.
- W2988401315 hasConceptScore W2988401315C71924100 @default.
- W2988401315 hasConceptScore W2988401315C72563966 @default.
- W2988401315 hasConceptScore W2988401315C84393581 @default.
- W2988401315 hasIssue "4" @default.
- W2988401315 hasLocation W29884013151 @default.
- W2988401315 hasLocation W29884013152 @default.
- W2988401315 hasLocation W29884013153 @default.
- W2988401315 hasLocation W29884013154 @default.
- W2988401315 hasOpenAccess W2988401315 @default.
- W2988401315 hasPrimaryLocation W29884013151 @default.
- W2988401315 hasRelatedWork W136137370 @default.
- W2988401315 hasRelatedWork W1986224413 @default.
- W2988401315 hasRelatedWork W2004733887 @default.
- W2988401315 hasRelatedWork W2089715561 @default.
- W2988401315 hasRelatedWork W2356526470 @default.
- W2988401315 hasRelatedWork W2475182459 @default.
- W2988401315 hasRelatedWork W2603773853 @default.
- W2988401315 hasRelatedWork W2786094415 @default.
- W2988401315 hasRelatedWork W3088205044 @default.
- W2988401315 hasRelatedWork W4256514411 @default.
- W2988401315 hasVolume "10" @default.